Immunology Market: A Deep Dive Into Factors that will Help Vendors Stay Ahead of Competitors - Technavio

The immunology market is fragmented. The market is expected to witness intense competition among vendors because of the adoption of disruptive strategies. The global immunology market also compromises new academic start-ups. Due to the lack of financial backing, these small immunology drug players with high-potential products are being acquired by bigger players. Moreover, intense competition and declining profit margins are significant risk factors for the vendors.

Key Vendor Strategies to Overcome Market Challenges

Key strategies used by vendors to overcome the above challenges have been identified by Technavio. The opportunities for new entrants in the development of immunomodulatory therapies will be enhanced, with the expiry of patents of branded therapeutics in anti-histamines, B/T-cell suppressive agents, and corticosteroids. Therefore, to survive and succeed in this intensely competitive environment, it becomes imperative for vendors to differentiate their product and service offerings through clear and unique value propositions.

Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now

Market Growth Potential

The immunology market size is expected to grow by USD 55.00 billion from 2021 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 8.45% during the forecast period.

Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format

Factors that will Drive the Market

Vendors in the immunology market can take advantage of a few factors that will work in their favor. One of these factors includes growing organ transplantation. Ongoing commitment and combined efforts of organ procurement organizations, hospitals, and the Organ Procurement and Transplantation Network (OPTN) are contributing to the rise in organ transplantations. Thus, the increasing number of organ transplantations is expected to drive the demand for immunosuppressive drugs, which, in turn, will fuel the growth of the global immunology market during the forecast period.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

Related Reports

Pharmacogenomics Market by End-user and Geography - Forecast and Analysis 2022-2026: The market's varying regulations on pharmacogenomics testing and research globally are challenging market growth.

Clinical Trial Support Services Market Application, Age Group, and Geography - Forecast and Analysis 2022-2026: High cost of clinical trials may challenge the market growth

Browse Health Care Market Reports

Table of Contents

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Category

• Market segments
• Comparison by Category
• Immunosuppressants - Market size and forecast 2020-2025
• Immuno boosters - Market size and forecast 2020-2025
• Market opportunity by Category

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AbbVie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Johnson and Johnson Inc.
• Novartis AG
• Pfizer Inc.
• Sumitomo Dainippon Pharma Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• UCB SA

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Newsroom: newsroom.technavio.com/news/immunologymarket

SOURCE Technavio